EDSA

Edesa Biotech Inc. is a clinical-stage biopharmaceutical company headquartered in Markham, Canada, specializing in the research and development of innovative therapies for inflammatory and immune-related diseases. With a robust pipeline focused on addressing unmet medical needs, Edesa leverages its proprietary technologies to advance treatments in areas such as dermatological and gastrointestinal disorders. As the company progresses through clinical trials, it aims to establish itself as a significant player in the biotherapeutics market, committed to improving patient outcomes through scientific innovation.